NDC 70518-1464

VERAPAMIL HYDROCHLORIDE

Verapamil Hydrochloride

VERAPAMIL HYDROCHLORIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Verapamil Hydrochloride.

Product ID70518-1464_7770a43f-b445-140b-e053-2991aa0a4816
NDC70518-1464
Product TypeHuman Prescription Drug
Proprietary NameVERAPAMIL HYDROCHLORIDE
Generic NameVerapamil Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-10-04
Marketing CategoryANDA / ANDA
Application NumberANDA071881
Labeler NameREMEDYREPACK INC.
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength120 mg/1
Pharm ClassesP-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 70518-1464-0

30 TABLET in 1 BLISTER PACK (70518-1464-0)
Marketing Start Date2018-10-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-1464-0 [70518146400]

VERAPAMIL HYDROCHLORIDE TABLET
Marketing CategoryANDA
Application NumberANDA071881
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-10-04

Drug Details

Active Ingredients

IngredientStrength
VERAPAMIL HYDROCHLORIDE120 mg/1

OpenFDA Data

SPL SET ID:e7d91a3d-71a6-4bd5-baed-6727d5b63285
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897666

    • Pharmacological Class

    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]